CH3 BioSystems
Methylation Biology Leader
CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates. The company offers unique cell lines for research and drug discovery. They manufacture novel molecular tools that facilitate biomedical research. Their goal is a better understanding of cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.
Product Range:
- Antibodies
- Cell Lines
- Enzymes
- Peptides
- Expression Vector
- shRNA Vector
- Luciferase Reporters
Biogenex
Molecular pathology systems
GenomeMe
IHC monoclonal antibodies
RayBiotech
Proteomic discovery tools
BBI Solutions
Diagnostic raw materials
Hillgene
Innovative products for cell and gene therapy